Abstract
s / Pancreatology 15 (2015) S1eS141 S97 Patients & methods: From 1/1/2010 to 1/1/2014 183 patients underwent a resective procedure in our institution for pancreatic adenocarcinoma. 25 had a preoperative value of CA19-9>1000 u/ml with serum bilirubin 0,05). Mean DFS was 23.1 vs 25.0 months (p1⁄40.49) (groupC vs M) and OS 28.6 vs 30.3 months (p>0,05). In the same period only 5 patients with CA 19-9>1000 u/ml underwent non-resective surgery after exploration. In C group 10 patients were alive 2 year after the resection. Conclusion: Despite CA19-9 prognostic role OS DFS of groupC patients are comparable with others resected patients and superior to non resected patients. High serum CA19-9 is not a contraindication to surgery if a correct preoperative workout is done.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
